Cargando…

HbA1c is a predictive factor of severe coronary stenosis and major adverse cardiovascular events in patients with both type 2 diabetes and coronary heart disease

BACKGROUND: Coronary heart disease (CHD) is not only a macrovascular complication of type 2 diabetes mellitus (T2DM). Cardiovascular disease (CVD) is one of the leading causes of mortality among individuals with T2DM. Reducing the risk of adverse cardiovascular events (MACE) is crucial for the manag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Xiaojuan, Zhang, Qin, Peng, Ping, Shen, Yunfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026512/ https://www.ncbi.nlm.nih.gov/pubmed/36935502 http://dx.doi.org/10.1186/s13098-023-01015-y

Ejemplares similares

HbA1c, Coronary atheroma progression and cardiovascular outcomes
por: Dykun, Iryna, et al.
Publicado: (2022)

HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients
por: Zhao, Wenhui, et al.
Publicado: (2014)

The relationship between HbA1c and cardiovascular events in diabetic patients with coronary angioplasty: A cross-sectional study
por: Adel, Seyed Mohammad Hassan, et al.
Publicado: (2022)

Up‐regulation of long non‐coding RNA THRIL in coronary heart disease: Prediction for disease risk, correlation with inflammation, coronary artery stenosis, and major adverse cardiovascular events
por: Qi, Haijun, et al.
Publicado: (2020)

Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis
por: Jiao, Xiaojuan, et al.
Publicado: (2022)

Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events
por: Song, Mowei, et al.
Publicado: (2023)

Postprandial Blood Glucose Outweighs Fasting Blood Glucose and HbA1c in screening Coronary Heart Disease
por: Jiang, Jingjing, et al.
Publicado: (2017)

The Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome
por: Xu, Shaodong, et al.
Publicado: (2022)

The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years
por: Du, Jinling, et al.
Publicado: (2016)

Retracted: The Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Risk factors for major adverse cardiovascular events after the first acute coronary syndrome
por: Okkonen, Marjo, et al.
Publicado: (2021)

HbA1c at term delivery and adverse pregnancy outcome
por: Hong, Jesrine Gek Shan, et al.
Publicado: (2022)

Effect of the index of cardiac electrophysiological balance on major adverse cardiovascular events in patients with diabetes complicated with coronary heart disease
por: Lin, Yuan, et al.
Publicado: (2023)

Associations of Modified Healthy Aging Index With Major Adverse Cardiac Events, Major Coronary Events, and Ischemic Heart Disease
por: Huang, Ninghao, et al.
Publicado: (2023)

HbA(1c) for Diabetes Screening in Acute Coronary Syndrome: time for a reappraisal of the guidelines?
por: McCune, C, et al.
Publicado: (2015)

Clinical implication of homocysteine in premature acute coronary syndrome female patients: Its distribution and association with clinical characteristics and major adverse cardiovascular events risk
por: Zhao, Yunfeng, et al.
Publicado: (2021)

Current Progress of Studies of Coronary CT for Risk Prediction of Major Adverse Cardiovascular Event (MACE)
por: Zheng, Jianan, et al.
Publicado: (2021)

Predictive value of coronary stenosis degree combined with CT-FFR and resting-state CTP for major adverse cardiac events in obstructive coronary artery disease
por: Yang, Fei, et al.
Publicado: (2023)

Association between the triglyceride-glucose index and 1-year major adverse cardiovascular events in patients with coronary heart disease and hypertension
por: Tao, Shiyi, et al.
Publicado: (2023)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
por: Ikebe, So, et al.
Publicado: (2023)

The burden of major adverse cardiac events in patients with coronary artery disease
por: Tsai, I-Ting, et al.
Publicado: (2017)

Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China
por: Hu, Chengping, et al.
Publicado: (2020)

Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
por: Pei, Junyu, et al.
Publicado: (2023)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

Performance of HbA(1c) and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography
por: Wang, Jun-Sing, et al.
Publicado: (2013)

HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2022)

Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions
por: Chen, Jingyang, et al.
Publicado: (2023)

Standardization of the HbA(2) Assay
por: Paleari, Renata, et al.
Publicado: (2018)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Kong, Shuting, et al.
Publicado: (2021)

Dietary patterns and the risk of major adverse cardiovascular events in a global study of high-risk patients with stable coronary heart disease
por: Stewart, Ralph A. H., et al.
Publicado: (2016)

Cardiac scoring systems, coronary artery disease and major adverse cardiovascular events: A scoping review
por: Premsagar, Preesha, et al.
Publicado: (2023)

Risk of major adverse cardiovascular events in subjects with asymptomatic mild carotid artery stenosis
por: Kwon, Hyunwook, et al.
Publicado: (2018)

Distribution of FFRCT in single obstructive coronary stenosis and predictors for major adverse cardiac events: a propensity score matching study
por: Jin, Xianglan, et al.
Publicado: (2022)

The association between maternal HbA1c and adverse outcomes in gestational diabetes
por: Muhuza, Marie Parfaite Uwimana, et al.
Publicado: (2023)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2012)

New-Onset Diabetes in Elderly Subjects: Association between HbA(1c) levels, mortality, and coronary revascularization
por: Twito, Orit, et al.
Publicado: (2013)

HbA1c Screening for Diabetes in Patients with Acute Coronary Syndrome: A Worthwhile Test or a Pitfall?
por: Józwa, Robert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9l339e5en2scitn22gpm0ebsc7